DrugDashboards

Fexofenadine HCl and Pseudoephedrine HCI

Fexofenadine HCl and Pseudoephedrine HCI · FEXOFENADINE HYDROCHLORIDE 60 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 120 mg/1 · Tablet, Extended Release · Oral · Dr. Reddy's Laboratories Limited

NDC 55111-0447-14 · 4 BLISTER PACK in 1 CARTON / 5 TABLET, EXTENDED RELEASE in 1 BLISTER PACK · ANDA · View full market →

The short version

8 companies supply this market — a reasonable cushion if one runs into trouble. The price is up 16% over the past year, to $0.4781 per unit. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$0.25$0.5$0.75Sep 2016Sep 2026$0.4781
59 price points · per EASource: CMS NADAC

Estimated fill cost

#30 count
$14.34
#90 count
$43.03

Estimates: latest NADAC unit price × quantity. Pharmacy acquisition cost only — excludes dispensing fees, markup, and insurance terms.

Medicaid spend (2022)

$1,378
66 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

0Low risk

Nothing here is signaling trouble: several manufacturers, no current shortage, no recent serious recalls, stable pricing. In drug supply, boring is the good outcome.

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.2%chance of a new FDA shortage posting for fexofenadine hcl and pseudoephedrine hci (oral solid) in the next 90 days

price up 16% YoY · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Regulatory

Application
ANDA076667
TE code
Approval date
Nov 18, 2014
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Fexofenadine HCl and Pseudoephedrine HCI (Tablet, Extended Release)

LabelerStrengthFirst seenLast seen
Dr. Reddy's Laboratories Inc.FEXOFENADINE HYDROCHLORIDE 60 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 120 mg/1Jul 15, 2026Sep 3, 2026
The Kroger Co.FEXOFENADINE HYDROCHLORIDE 60 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 120 mg/1Jul 15, 2026Sep 3, 2026
CVS PharmacyFEXOFENADINE HYDROCHLORIDE 60 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 120 mg/1Jul 15, 2026Sep 2, 2026
Dr. Reddy's Laboratories LimitedFEXOFENADINE HYDROCHLORIDE 60 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 120 mg/1Jul 15, 2026Sep 2, 2026
Dr.Reddy's Laboratories LimitedFEXOFENADINE HYDROCHLORIDE 180 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 240 mg/1Jul 15, 2026Sep 2, 2026
HebFEXOFENADINE HYDROCHLORIDE 60 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 120 mg/1Jul 15, 2026Sep 2, 2026
Rite Aid CorporationFEXOFENADINE HYDROCHLORIDE 60 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 120 mg/1Jul 15, 2026Sep 2, 2026
Walgreens CompanyFEXOFENADINE HYDROCHLORIDE 60 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 120 mg/1Jul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Fexofenadine HCl and Pseudoephedrine HCI — NDC 55111-0447-14," retrieved September 3, 2026, https://drugdashboards.com/drug/55111044714.

Free to cite with attribution — see how the data is put together.